Canadian evacuees arriving from China to be quarantined at CFB Trenton

By The Canadian Press

Canadian evacuees from the Chinese province afflicted with the novel coronavirus will be quarantined for two weeks upon their arrival at an Ontario military base, the government announced Sunday night.

But Ottawa did not provide a timeline for when they’ll arrive from the locked-down city of Wuhan, saying it’s still awaiting final approval from Chinese authorities. Their plane will land at Canadian Forces Base Trenton.

“To protect the health and safety of Canadians – both those who are coming to and those already in Canada – the returning individuals will undergo a thorough health screening before boarding, during the flight and upon arrival at CFB Trenton, Ontario,” said a statement from Global Affairs Canada.

“All other returning Canadians, including staff and flight crew, will remain at CFB Trenton for 14 days for further medical assessment and observation, and be provided with all the necessary medical and other supports as needed to ensure the health and safety of all Canadians.”

Until Sunday, the federal government hasn’t said whether Canadians who eventually arrive from China would be quarantined. But officials said they were closely watching developments in other countries, including the United States.

Nearly 200 Americans have already been evacuated from Wuhan, and U.S. health officials ordered that they be quarantined for two weeks. It was the first time a federal quarantine has been ordered in that country since the 1960s, when one was enacted over concern about potential spread of smallpox, the Centers for Disease Control and Prevention said.

South Korea, too, quarantined its evacuees, who arrived in Seoul on Friday. They underwent screenings for fever before boarding buses to quarantine facilities established in the central towns of Asan and Jincheon. Residents there have protested plans to place the evacuees in their neighbourhoods, throwing eggs and other objects at visiting government officials.

The Australian government was forced to defend its plan, which involved sending evacuees to Christmas Island, which has been used to banish asylum seekers and convicted criminals. Critics warned that some Australians would prefer to stay in China rather than go there.

“The government remains fully engaged on the issue, and will do all that is necessary to ensure the safety of Canadians, both at home and abroad,” said a statement from Prime Minister Justin Trudeau’s office after a meeting of senior cabinet members where the plan to quarantine at the Trenton military base was discussed.

The number of Canadians who want to flee the Chinese province afflicted by the virus climbed to 325 on Sunday.

Global Affairs Canada provided the updated figure on Sunday, as the world saw its first case of a person dying from the new coronavirus outside of China – a 44-year-old man in the Philippines.

“This has been a rapidly evolving situation and the number of Canadians asking for assistance is quickly changing,” said a statement from the department.

Global Affairs Canada said government officials and military personnel are currently en route to Hanoi, Vietnam, and in the process of obtaining visas from the Chinese government to enter Wuhan.

It said the government has chartered a plane to land in Hanoi and then head to Wuhan, where airspace is currently closed, once it gets approval from the Chinese government.

But there was no indication Sunday from Global Affairs about the status of that flight.

The department was, however, telling people not to go to the airport unannounced because they will not be permitted to board the aircraft. Instead, they were told to contact its Emergency Watch and Response Centre in Ottawa to make arrangements.

“Canada is chartering a plane to take Canadians from Wuhan, China back to Canada. We have 325 requests for departure assistance from Hubei Province and we will be reaching out to provide updates and to confirm their needs in order to assist our logistical planning,” the department said in a statement.

“Spaces will be limited and not guaranteed, and will likely only be confirmed with very little notice.”

Canada is consulting with the United States and Britain “to ensure co-operation and sharing of best practices in this operation,” the statement said.

China says 361 have died on the mainland from the new virus, with an additional 2,829 new cases over the last 24 hours bringing the Chinese total to 17,205.

The latest figures, released on Monday in China, come a day after the first death from the illness was recorded outside the country, in the Philippines, as countries around the world evacuated hundreds of their citizens from the infection zone.

Canada has four known cases – three in Ontario and one in British Columbia.

On Sunday, a second French-chartered plane carrying 300 evacuees from China landed at the military base of Istres in the southern French region of Bouches-du-Rhone. That followed the first French plane that landed on Friday.

In spite of the widespread fear of the virus, health officials in Canada have said chances of contracting it in this country are exceptionally low. They said people should take normal cold- and flu-season precautions of frequent hand-washing and covering coughs and sneezes.

Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

6h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

6h ago

Most Watched Today